{
    "body": "What is the risk of developing acute myelogenous leukemia in Fanconi anemia?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/8068955", 
        "http://www.ncbi.nlm.nih.gov/pubmed/9207444", 
        "http://www.ncbi.nlm.nih.gov/pubmed/1548931"
    ], 
    "ideal_answer": [
        "A review of all of the cases of Fanconi anemia (FA) reported to the International Fanconi Anemia Registry (IFAR) indicates that at least 15% manifest acute myelogenous leukemia (AML) or preleukemia.", 
        "A review of all of the cases of Fanconi anemia (FA) reported to the International Fanconi Anemia Registry (IFAR) indicates that at least 15% manifest acute myelogenous leukemia (AML) or preleukemia  "
    ], 
    "exact_answer": [
        "At least 15%, based on the International Fanconi Anemia Registry (IFAR)"
    ], 
    "concepts": [
        "http://www.disease-ontology.org/api/metadata/DOID:13636", 
        "http://www.disease-ontology.org/api/metadata/DOID:8692", 
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005199", 
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D051856", 
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D015470", 
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D007951"
    ], 
    "type": "factoid", 
    "id": "54ede76294afd61504000008", 
    "snippets": [
        {
            "offsetInBeginSection": 1440, 
            "offsetInEndSection": 1519, 
            "text": "Sixteen of the 59 FA-C patients (27%) have developed acute myelogenous leukemia", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9207444", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 827, 
            "offsetInEndSection": 895, 
            "text": "Actuarial risk of MDS or AML was 52% (37% to 67%) by 40 years of age", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/8068955", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 197, 
            "text": "A review of all of the cases of Fanconi anemia (FA) reported to the International Fanconi Anemia Registry (IFAR) indicates that at least 15% manifest acute myelogenous leukemia (AML) or preleukemia", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/1548931", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 198, 
            "text": "A review of all of the cases of Fanconi anemia (FA) reported to the International Fanconi Anemia Registry (IFAR) indicates that at least 15% manifest acute myelogenous leukemia (AML) or preleukemia.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/1548931", 
            "endSection": "abstract"
        }
    ]
}